Urate-Lowering Therapy Inhibits Thoracic Aortic Aneurysm and Dissection Formation in Mice

Arterioscler Thromb Vasc Biol. 2023 Jun;43(6):e172-e189. doi: 10.1161/ATVBAHA.122.318788. Epub 2023 Apr 27.

Abstract

Background: Thoracic aortic aneurysm and dissection (TAAD) is a highly lethal vascular disease without effective drug therapy. Whether elevated serum concentrations of uric acid are involved in TAAD development remains unclear.

Methods: Serum uric acid levels were detected in different TAAD mouse models and patients. The urate-lowering drug allopurinol was administered in the drinking water of TAAD mice. Adenine diet-induced mice were established to investigate the role of hyperuricemia in TAAD formation and RNA-sequencing of thoracic aortas from these mice was performed.

Results: We found serum uric acid levels were elevated in various mouse TAAD models, including mice fed a β-aminopropionitrile diet, Marfan mice with fibrillin-1 haploinsufficiency (Fbn1C1041G/+), and ApoE-/- mice infused with Ang II (angiotensin II), as well as in patients with TAAD. Administration of urate-lowering drug allopurinol in the drinking water significantly alleviated TAAD formation in β-aminopropionitrile-treated mice, Fbn1C1041G/+ mice, and Ang II-infused ApoE-/- mice. Moreover, an adenine diet was used to induce hyperuricemia in mice. Intriguingly, a 4-week adenine diet feeding directly induced TAAD formation characterized by increased maximal thoracic aortic diameters and severe elastin degradation, which were ameliorated by allopurinol. Unbiased RNA-sequencing in mouse thoracic aortas suggested that FcγR (Fc gamma receptor) was upregulated upon adenine diet, but reciprocally repressed by allopurinol. Mechanistically, hyperuricemia activated FcγR-mediated ERK1/2 (extracellular signal-regulated kinase 1/2) phosphorylation to induce macrophage inflammation and TAAD development, which was abrogated by allopurinol or FcγR deficiency.

Conclusions: This study uncovered an important and previously unrecognized role of hyperuricemia in mediating the pathogenesis of TAAD, and uric acid-lowering drug may represent a promising therapeutic approach for TAAD.

Keywords: allopurinol; aortic aneurysm, thoracic; aortic dissection; hyperuricemia; inflammation; receptors, IgG.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allopurinol / adverse effects
  • Aminopropionitrile / adverse effects
  • Animals
  • Aortic Aneurysm, Thoracic* / chemically induced
  • Aortic Aneurysm, Thoracic* / genetics
  • Aortic Aneurysm, Thoracic* / prevention & control
  • Aortic Dissection* / chemically induced
  • Aortic Dissection* / genetics
  • Aortic Dissection* / prevention & control
  • Disease Models, Animal
  • Drinking Water* / adverse effects
  • Hyperuricemia* / chemically induced
  • Hyperuricemia* / drug therapy
  • Mice
  • Mice, Inbred C57BL
  • RNA
  • Receptors, IgG
  • Signal Transduction
  • Uric Acid

Substances

  • Uric Acid
  • Aminopropionitrile
  • 1,3,4,6-tetra-O-acetyl-2-azido-2-deoxyglucopyranose
  • Allopurinol
  • Drinking Water
  • Receptors, IgG
  • RNA